Registers 1.69M Shares for Resale, Potentially Diluting Existing Shareholders by 281%
BIAF sits 97% above its 52-week low of $4.56.
Summary
bioAffinity Technologies registered 1.69 million shares for resale by warrant holders, which could dilute existing shareholders by over 280% and create significant stock overhang.
Key Events · Financing and Capital Events · BIAF
-
Massive Potential Dilution
The company registered 1,692,408 shares for resale by selling stockholders, which, if all warrants are exercised and shares issued, would represent a 281.7% dilution to the 600,736 shares currently outstanding.
-
Warrant Exercise Prices Significantly Below Market
The shares are issuable upon exercise of pre-funded warrants at $0.105 per share and Series A/B warrants at $4.9757 per share. These exercise prices are substantially below the last reported sale price of $9.75 on September 2, 2026, making exercise highly likely.
-
No Direct Proceeds from Resale
The company will not receive any proceeds from the sale of shares by the selling stockholders. However, it could receive approximately $5.7 million if all warrants are exercised for cash, which would be critical for its cash runway.
-
Follows Recent Private Placement
These warrants were issued in a private placement that closed on August 14, 2026, which provided the company with approximately $3.5 million in net proceeds for working capital and general corporate purposes.
Analysis · BIAF · Industrial Applications And Services
This filing registers 1,692,408 shares of common stock for resale by selling stockholders, representing a potential dilution of 281.7% to the current outstanding shares. These shares are issuable upon the exercise of warrants issued in a private placement on August 14, 2026. While the company previously received $3.5 million from that private placement, this registration creates a significant overhang on the stock. The low exercise prices of the warrants ($0.105 and $4.9757) compared to the market price ($9.75 on September 2nd) make their exercise and subsequent resale highly probable, leading to substantial dilution for existing shareholders. This comes as the company faces a going concern warning and a Nasdaq delisting notice, making any significant dilution particularly impactful.
How filings like this one have moved
In the 30 days to Oct 17, 2026, 44.3% of the 298 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.35%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BIAF was trading at $9.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.4M. The 52-week trading range was $4.56 to $202.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.